Norwood术后残余病变对结局的影响
基于儿科心脏网络残余病变评分研究,回顾2015—2017年Norwood术后249例新生儿,按出院超声和临床特征分为残余病变1~3级。3级(主要残余病变)者12个月无移植生存更差(HR 3.08;95%CI 1.51~6.28;P=.002),存活且出院天数更少,但出院后再干预率无差异。
要点
- Norwood术后主要残余病变与12个月无移植生存更差相关
- 3级残余病变者12个月存活且出院天数少49天
- 残余病变等级与出院后再干预率无显著关联
核心结论
- Norwood术后主要残余病变与12个月无移植生存更差及存活且出院天数更少相关,但不增加出院后再干预率。
研究设计与样本
- 回顾性分析儿科心脏网络残余病变评分研究2015—2017年Norwood术后新生儿,共249例,239例可分级,206例存活出院。
主要发现
- 249例中52例(21%)于12个月死亡,含移植后3/4例;3级残余病变者12个月无移植生存低于1级(HR 3.08;95%CI 1.51~6.28;P=.002)。
- 192例可评估12个月存活且出院天数,3级残余病变者少49天。
- 206例存活出院者中残余病变评分与出院后再干预无关联,全局排名评分显示1、2级相对3级胜出比例更高。
关键数值与推荐
- 残余病变评分分1级(无残余)、2级(轻微残余)、3级(主要残余),于出院时经超声心动图和临床特征评估。
临床怎么用
- 对Norwood术后残余病变3级患者应加强密切随访,关注无移植生存与存活且出院天数。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Residual lesions may be important for both in-hospital and postdischarge outcomes following congenital heart surgery. We sought to understand their impact (measured by residual lesion score [RLS]) on the Norwood outcomes. METHODS: We reviewed outcomes post-Norwood procedure (2015-2017) in the Pediatric Heart Network's RLS study, including transplant-free survival, reinterventions, and days alive and out of the hospital at 12 months post-Norwood among survivors at Norwood discharge. Residual lesions were assessed by echocardiography and clinical characteristics at discharge. Global rank scores of outcomes of interest weighted by severity and win/loss ratios were calculated. RLS defined class 1 (no residua), class 2 (minor residua), and class 3 (major residua). RESULTS: Among 249 neonates, 239 could be assigned an RLS class. Of 206 survivors to hospital discharge, RLS was not associated with postdischarge reinterventions. At 12 months, 52 (21%) died, including 3/4 after transplant. Of 192 with follow-up to assess days alive and out of the hospital at 12 months post-Norwood, RLS class 3 had 49 fewer days. Transplant-free survival 12 months post-Norwood was lower for class 3 versus class 1 (hazard ratio, 3.08; 95% CI, 1.51, 6.28; P = .002). The global rank score identified a higher ratio of wins for RLS classes 1 and 2 versus class 3. CONCLUSIONS: Major residual lesions post-Norwood are associated with poorer transplant-free survival and fewer days alive and out of the hospital at 12 months but are not associated with increased rates of reintervention post-Norwood discharge. Global rank scores confirmed poorer outcomes in class 3. Given these findings, patients with RLS class 3 warrant close follow-up.
引用
- Nathan M, Van Rompay MI, Lambert LM, et al. Impact of residual lesions following Norwood palliation. J Thorac Cardiovasc Surg. 2026. PMID: 42697309. doi:10.1016/j.jtcvs.2026.08.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。